Drugs / Donor-derived Treg cell injection
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06920199 | Jun 2025 → May 2027 expected | chronic graft versus host disease | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor-derived Treg cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06920199 ↗ |
| Modality | Cell therapy | “Treg cell infusion at day D0” NCT06920199 ↗ |